My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Board of Transport Corporation of India declares 2nd interim dividend
Feb 03,2017

Transport Corporation of India announced that the Board of Directors of the Company at its meeting held on 02 February 2017, inter alia, has:

- Declared payment of 2nd Interim Dividend @25% (Re. 0.50 per share of face value of Rs. 2/- each) to the Shareholders. The payment of dividend/dispatch of warrants will be completed within 30 days of declaration of Interim Dividend i.e. on or before 03 March 2017.

Powered by Capital Market - Live News

Mahanagar Gas fixes record date for interim dividend
Feb 03,2017

Mahanagar Gas has fixed 20 February 2017 as the Record Date for the purpose of Payment of Interim Dividend, if approved.

Powered by Capital Market - Live News

Aegis Logistics to pay interim dividend
Feb 03,2017

Aegis Logistics has fixed 23 February 2017 as the payout date for payment of interim dividend.

Powered by Capital Market - Live News

Board of Aegis Logistics declares 2nd interim dividend
Feb 03,2017

Aegis Logistics announced that the Board of Directors of the Company at its meeting held on 02 February 2017, inter alia, have considered and approved / noted the following:

1. Declared 2nd Interim Dividend of 35% on equity shares of face value of Re.1/-i.e. Rs.0.35 (i.e. 35 paise) per share and the Company has fixed 23 February 2017 as the payout date for payment of Interim Dividend.

2. Exit offer to the public shareholders of the Companys subsidiary n++Sea Lord Containersn++ at a price of Rs.576.10 per share as determined by an Independent Valuer in accordance with the SEBI Circular dated October 10, 2016 and Section 236 of the Companies Act, 2013. Public shareholding in Sea Lord Containers as on date is 8.53% of the paid up capital

Powered by Capital Market - Live News

HSIL drops after weak Q3 results
Feb 03,2017

The announcement was made after market hours yesterday, 2 February 2017.

Meanwhile, the S&P BSE Sensex was down 24.96 points or 0.09% at 28,201.65.

On the BSE, 12,000 shares were traded on the counter so far as against the average daily volumes of 12,095 shares in the past one quarter. The stock had hit a high of Rs 290.15 and a low of Rs 282.70 so far during the day.

The stock had hit a 52-week high of Rs 369.50 on 24 August 2016 and a 52-week low of Rs 224 on 19 February 2016. The stock had underperformed the market over the past one month till 2 February 2017, advancing 4.51% compared with the Sensexs 6.13% rise. The scrip had also underperformed the market over the past one quarter, declining 15.08% as against the Sensexs 2.54% rise.

The small-cap company has equity capital of Rs 14.46 crore. Face value per share is Rs 2.

HSIL is engaged in the manufacture and distribution of sanitary-ware and glass containers primarily in India.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals jumps after posting strong Q3 results
Feb 03,2017

The result was announced after market hours yesterday, 2 February 2017.

Meanwhile, the BSE Sensex was up 8.45 points, or 0.03%, to 28,235.06.

More than usual volumes were witnessed on the counter. On the BSE, 84,933 shares were traded in the counter so far, compared with average daily volumes of 66,350 shares in the past one quarter. The stock had hit a high of Rs 970.25 and a low of Rs 950 so far during the day. The stock had hit a 52-week high of Rs 993 on 1 November 2016. The stock had hit a 52-week low of Rs 671.50 on 12 February 2016.

The stock had underperformed the market over the past one month till 2 February 2017, rising 2.58% compared with 6.13% gains in the Sensex. The scrip had also underperformed the market in past one quarter, falling 3.49% as against Sensexs 2.54% gains.

The large-cap company has equity capital of Rs 28.22 crore. Face value per share is Re 1.

Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals said that the overall growth for the organization has been bolstered due to the strong performance by US formulation business. It was further aided by the good performance from Active Pharmaceutical Ingredients (API) business too. In India, considering the overall demand environment, the business still managed to record sales growth.

He added that during Q3, the company announced strategic blueprint for the next decade where the organizations focus will be directed to three therapeutic areas namely; oncology, respiratory and dermatology. Also, innovative pipeline continues to make good progress primarily on account of the bi-specific antibodies which are in clinical or pre-clinical development stage.

Glenmark Pharmaceuticals is a research‐driven, global, integrated pharmaceutical organization headquartered at Mumbai, India.

Powered by Capital Market - Live News

Kennametal India jumps after strong Q2 earnings
Feb 03,2017

The announcement was made after market hours yesterday, 2 February 2017.

Meanwhile, the S&P BSE Sensex was down 12.93 points or 0.05% at 28,213.68.

On the BSE, 5,425 shares were traded on the counter so far as against the average daily volumes of 2,162 shares in the past one quarter. The stock had hit a high of Rs 617 and a low of Rs 600 so far during the day.

The stock had hit a 52-week high of Rs 775.25 on 5 May 2016 and a 52-week low of Rs 555 yesterday, 2 February 2017. The stock had underperformed the market over the past one month till 2 February 2017, sliding 2.4% compared with the Sensexs 6.13% rise. The scrip had, however, underperformed the market over the past one quarter, declining 10.02% as against the Sensexs 2.54% rise.

The small-cap company has equity capital of Rs 21.98 crore. Face value per share is Rs 10.

Kennametal India is a manufacturer of hard metal products and machine tools for the manufacturing industries, including auto and auto ancillaries, light and general engineering industries.

Powered by Capital Market - Live News

Granules India intimates of successful completion of re-inspection of Gagillapur facility
Feb 03,2017

Granules India announced the successful completion of re-inspection of its Gagillapur facility in Telangana by INFRAMED, Portugal. The re-inspection of the said facility was conducted by INFRAMED from 31 January to 02 February 2017.

Powered by Capital Market - Live News

Granules India intimates of successful completion of re-inspection of Gagillapur facility
Feb 03,2017

Granules India announced the successful completion of re-inspection of its Gagillapur facility in Telangana by INFRAMED, Portugal. The re-inspection of the said facility was conducted by INFRAMED from 31 January to 02 February 2017.

Powered by Capital Market - Live News

Axis Bank gains after board approves allotment of senior notes
Feb 03,2017

The announcement was made after market hours yesterday, 2 February 2017.

Meanwhile, the BSE Sensex was down 7.50 points, or 0.07%, to 28,207.60.

On the BSE, 17,663 shares were traded in the counter so far, compared with average daily volume of 5.18 lakh shares in the past one quarter. The stock had hit a high of Rs 487.50 and a low of Rs 483 so far during the day.

Axis Bank announced that the board of directors of the bank has passed a resolution approving the allotment of 3 years senior floating rate notes aggregating to $10 million under the banks medium term note (MTN) Programme through its Dubai International Financial Centre (DIFC) branch.

Axis Banks net profit dropped 73.4% to Rs 579.57 crore on 15.7% growth in total income to Rs 14501.21 crore in Q3 December 2016 over Q3 December 2015.

Axis Bank is one of the biggest private sector banks in India.

Powered by Capital Market - Live News

Bombay Burmah Trading Corporation redeems Commercial Paper aggregating Rs 50 crore
Feb 03,2017

Bombay Burmah Trading Corporation announced that Commercial paper issued by the Corporation on 04 November 2016 for Rs.50 crore with Maturity date of 02 February 2017 has been redeemed.

Powered by Capital Market - Live News

Bombay Burmah Trading Corporation redeems Commercial Paper aggregating Rs 50 crore
Feb 03,2017

Bombay Burmah Trading Corporation announced that Commercial paper issued by the Corporation on 04 November 2016 for Rs.50 crore with Maturity date of 02 February 2017 has been redeemed.

Powered by Capital Market - Live News

Board of Cravatex approves acquisition of Cravatex Brands and business transfer agreement
Feb 03,2017

Cravatex announced that the Board of Directors of the Company at its meeting held on 02 February 2017 transacted the following -

Approved acquisition of 100% equity stake (3000 equity shares) of Cravatex Brands by the Company, resulting in Cravatex Brands becoming a wholly owned subsidiary of the Company.

Approved the sale and transfer of Companys business of import, marketing and distribution and servicing of fitness equipment as well as through licensing arrangements with global brands the marketing, distribution and retail of footwear, apparel and sporting goods to Cravatex Brands for a lump sum consideration of Rs 32.68 crore. The said lump sum will be discharged by Cravatex Brands by issue and allotment to the Company 32.68 lakh equity shares of Cravatex Brands.

Powered by Capital Market - Live News

Parag Milk Foods launches new product Avataar Absolute Whey Protein
Feb 03,2017

Parag Milk Foods has launched new product Absolute Whey Protein with the brand name Avataar on 01 February 2017. The product is available in Double Chocolate flavour in pack sizes of 2 LBS and 5 LBS.

Powered by Capital Market - Live News

Shares of Raideep Industries get listed
Feb 03,2017

The equity shares of Raideep Industries (Scrip Code: 540270) are listed effective 03 February 2017 and admitted to dealings on the Exchange in the list of XT Group Securities.

Powered by Capital Market - Live News